No description available.

G-protein pathway suppressor 2 (GPS2) is a 36kD protein involved in a number of regulatory functions in key metabolic organs. First discovered as a suppressor of the RAS- and MAPK- signaling pathways, GPS2 is subsequently identified as part of the NCoR/SMRT corepressor complex that play an important regulatory role in gene transcription, and GPS2 is also involved in meiotic recombination in the nucleus. Recently, we identified a non-transcriptional role of GPS2 as an inhibitor of the pro-inflammatory JNK pathway activation in response to tumor necrosis factor alpha (TNF-a;) in the cytosol. This suggests that GPS2 function may be dependent on its cellular localization. However, an understanding of how GPS2 differentially target cellular compartments is still lacking. In this study, we show that a tightly controlled balance between GPS2 protein stabilization and degradation regulates the function of nuclear GPS2. Our results reveal that methylation by arginine methyltransferase PRMT6 and interaction with exchange factor TBL1 cooperate to protect GPS2 from Siah2-dependent proteasomal degradation, thus promoting GPS2 nuclear localization. In addition, our results link GPS2 protein instability to decreased nuclear-encoded mitochondrial gene expression, suggesting that GPS2 may play an important role in regulating mitochondrial oxidative capacity, whose imbalance has been linked to chronic inflammation and insulin resistance. In conclusion, our findings illustrate post-transcriptional modification is important in the regulation of GPS2 cellular function. Understanding such molecular regulation of GPS2 is critical in furthering future efforts to investigate its roles in cellular homeostasis and inflammatory responses.

MicroRNAs (miRNAs) are a class of small, single-stranded, non-protein coding RNA molecules that regulate cellular messenger RNA (mRNA) and protein levels by binding to specific mRNAs. Aberrant miRNA expression has been shown to be implicated in several diseases, including cancer. Extracellular miRNAs have been found to circulate in the bloodstream and some of their levels have been associated with different diseases. Furthermore, they hold promise as tissue- and blood-based biomarkers for cancer classification and prognostication. Blood-based biomarkers are attractive for cancer screening due to their minimal invasiveness, relatively low cost and ease of reproducibility. New miRNA analysis techniques will add toward the understanding of their biological functions. In this thesis, I investigate the utility of capillary electrophoresis (CE) and mass spectrometry (MS) for analysis of miRNAs through proof-of-concept experiments. In the fi rst part of this work, we developed a Protein-Facilitated Affinity Capillary Electrophoresis (ProFACE) assay for rapid quantification of miRNA levels in blood serum (see List of publications (6)). We also implemented a capillary electrophoresis with laser induced fluorescence detection (CE-LIF) method with online sample pre-concentration for detection of endogenous microRNAs in human serum and cancer cells. 3' modification of miRNA is a physiological and common post-transcriptional event that shows selectivity for specific miRNAs and is observed across species. Recent studies have shown that post-transcriptional addition of nucleotides to the 3' end of miRNAs is a mechanism for miRNA activity regulation. For example, such modifications in plants and C. elegans influence miRNA stability. In humans, effects on miRNA stability and on mRNA target repression have both been observed. Thus, there is a need for miRNA detection techniques which are direct and multiplexed, require minimal sample preparation and provide qualitative information regarding these modifications. We developed a multiplexed miRNA detection technique based on capillary electrophoresis coupled on line with electrospray ionization mass spectrometry (CE-ESI-MS). This method allowed a label-free, direct detection of multiple miRNAs extracted from cancer serum as well as their post-transcriptional modifications with a high mass accuracy.

Ces vingt dernières années, les réactions d'insertion d'atomes ou de fragments moléculaires dans des liaisons C-H peu réactives ont fait l'objet de nombreuses études sans que les mécanismes de ces réactions aient pu être établis. Les enzymes de la superfamille « Radical-SAM » catalysent l'activation de leur substrat en utilisant un centre [4Fe-4S] et le co-substrat S-adénosylméthionine (SAM). Les enzymes d'insertion radicalaire constituent un sous-groupe de cette famille et contiennent un second centre fer-soufre impliqué, lui, dans l'activation du deuxième substrat rendant ainsi possible la réaction d'insertion par couplage radicalaire. Le travail présenté dans cette thèse concerne deux de ces enzymes, la première, RimO, est une méthylthiotransférase (MTTase) qui catalyse l'insertion d'un groupement thiométhyle en beta du résidu D89 de la protéine ribosomale S12 (β-ms-D89-S12). La seconde TYW1 ou 4-demethylwyosine synthase catalyse l'insertion d'un groupement acétyle dérivé du pyruvate dans une liaison C-H d'un groupement N-CH3 appartenant à une guanine spécifique de certains ARNt eucaryotes. Cette réaction d'insertion est suivie d'une cyclisation conduisant en plusieurs étapes à la wybutosine (yW), une base tricyclique importante pour la fidélité traductionnelle de la cellule. Dans ce travail il a été montré que les deux centres de cette famille d'enzyme coopèrent pour ces réactions et contrôlent l'utilisation des différents acteurs par des mécanismes redox originaux. / Over the last twenty years, the insertion reactions of atoms or molecular fragments into poorly reactive C-H bonds have been actively investigated but the details of their mechanisms remain largely unknown. Enzymes belonging to the "Radical-SAM" superfamily catalyze the activation of their substrate using a [4Fe-4S] in conjunction with the co-substrate S-adenosylmethionine (SAM). Radical insertion enzymes are a subgroup of this family and contain a second iron-sulfur cluster involved in the activation of the second substrate allowing the insertion reaction by radical coupling to take place. The work presented in this thesis is focusing on two enzymes, the first one, RimO is a methylthiotransferase (MTTase) that catalyzes the insertion of a thiomethyl group on the beta position of D89 residue of the ribosomal protein S12 (β-ms-D89-S12). The second one, TYW1, or 4-demethylwyosine synthase, catalyzes the insertion of the acetyl moiety of pyruvate into a C-H bond of a N-methyl group of a guanine derivative in some eukaryotic and archeal tRNAs. This insertion reaction leads to the formation of a tricyclic ring and through several steps to wybutosine (yW), a hypermodified nucleotide important for the translational fidelity of the cell. In this work we demonstrate that these radical inserting enzymes utilize the two iron-sulfur clusters to cooperate and that they control the different partners of the reaction by original redox mechanisms.

Escherichia coli ribosomal RNA (rRNA) is post-transcriptionally modified by site-specific enzymes. The role of most modifications is not known and little is known about how these enzymes recognize their target substrates. In this thesis, we have structurally and functionally characterized two S-adenosyl-methionine (SAM) dependent 23S rRNA methyltransferases (MTases) that act during the early stages of ribosome assembly in E. coli. RlmM methylates the 2'O-ribose of C2498 in 23S rRNA. We have solved crystal structures of apo RlmM at 1.9Å resolution and of an RlmM-SAM complex at 2.6Å resolution. The RlmM structure revealed an N-terminal THUMP domain and a C-terminal catalytic Rossmann-fold MTase domain. A continuous patch of conserved positive charge on the RlmM surface is likely used for RNA substrate recognition. The SAM-binding site is open and shallow, suggesting that the RNA substrate may be required for tight cofactor binding. Further, we have shown RlmM MTase activity on in vitro transcribed 23S rRNA and its domain V. RlmJ methylates the exocyclic N6 atom of A2030 in 23S rRNA. The 1.85Å crystal structure of RlmJ revealed a Rossmann-fold MTase domain with an inserted small subdomain unique to the RlmJ family. The 1.95Å structure of the RlmJ-SAH-AMP complex revealed that ligand binding induces structural rearrangements in the four loop regions surrounding the active site. The active site of RlmJ is similar to N6-adenine DNA MTases. We have shown RlmJ MTase activity on in vitro transcribed 23S rRNA and a minimal substrate corresponding to helix 72, specific for adenosine. Mutagenesis experiments show that residues Y4, H6, K18 and D164 are critical for catalytic activity. These findings have furthered our understanding of the structure, evolution, substrate recognition and mechanism of rRNA MTases.